Knowledge on rare diseases and orphan drugs
COVID-19 & Rare diseases
Rare Diseases Resources for Refugees/Displaced Persons
Search for a rare disease
Limited systemic sclerosis
Limited systemic sclerosis (lSSc) (or SSc sine scleroderma) is a subset of systemic sclerosis (SSc) characterized by organ involvement in the absence of fibrosis of the skin.
ORPHA:220407
Prevalence is unknown.
Patients do not have skin fibrosis but only Raynaud's phenomenon, and are at risk of organ involvement (fibrosis and vascular obliteration of lungs, heart, digestive tract). They can later present with esophageal dysmotility which provokes gastroesophageal reflux and sometimes dysphagia, and can also suffer from lung fibrosis and pulmonary arterial hypertension.
The exact cause of lSSc is unknown. The disease originates from an autoimmune reaction which leads to overproduction of collagen. In some cases, SSc is associated with exposure to chemicals (silica, solvents, hydrocarbons, etc.).
Diagnosis can be difficult due to the absence of skin involvement. Nailfold capillaroscopy shows a SSc pattern and blood tests show a high incidence of anti-centromere antibodies.
Last update: July 2010 - Expert reviewer(s): Pr Eric HACHULLA
: produced/endorsed by ERN(s)
: produced/endorsed by FSMR(s)
General public
Guidelines
Disease review articles
Disability
Further information on this disease
Patient-centred resources for this disease
Research activities on this disease
- Research project(s) (48)
- Clinical trial(s) (17)
- Biobank(s) (5)
- Registry(ies) (34)
- Network of experts (7)
Newborn screening